Diagnostic Efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions
Abstract
Background: The findings of this study suggest that the Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound risk stratification system are scoring algorithm that can be applied to a non-selected population of women undergoing ultrasonography examinations in radiology departments with similar diagnostic performance compared with previously studied populations. Aim of study: The study aimed to evaluate the ovarian lesions as regarding malignancy rate, the validity and reliability through different pathological results and other imaging modalities mainly the MRI. Patients and Methods: This study is a prospective study included seventy seven patients (fifty pre and twenty seven postmenopausal) referred from out- patient oncology clinics or in-patients at departments of South Egypt Cancer Institute (SECI) for assessing a suspicious adnexal mass lesion. Their ages ranged from 16- 75 years. Results: The studied lesions were as following as regard (the ORADS) 15 (16.7%), 38 (42.2%), 5 (5.6%), 4 (4.4%) and 28 (31.1%) lesions were classified as ORADS caterory-1, 2, 3, 4 and 5, respectively. The main findings in the current study were that O-RADS at cutoff point> 4; it has 96.6% overall accuracy in diagnosis of nature of ovarian lesions with area under curve (AUC) was 0.986. Conclusion: the ultrasound O-RADS classification system provide a crucial non-invasive diagnostic tool for suspected ovarian tumors to distinguish between benign and malignant neoplastic lesions,
(2024). Diagnostic Efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions. SECI Oncology Journal, 12(3), 280-289.
MLA
. "Diagnostic Efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions", SECI Oncology Journal, 12, 3, 2024, 280-289.
HARVARD
(2024). 'Diagnostic Efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions', SECI Oncology Journal, 12(3), pp. 280-289.
VANCOUVER
Diagnostic Efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions. SECI Oncology Journal, 2024; 12(3): 280-289.